Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN¿) by means of DSC and 1H NMR
Publication

Publications

Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN¿) by means of DSC and 1H NMR

Title
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN¿) by means of DSC and 1H NMR
Type
Article in International Scientific Journal
Year
2005
Authors
Zimmermann, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Souto, EB
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Muller, RH
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
Title: PHARMAZIEImported from Authenticus Search for Journal Publications
Vol. 60
Pages: 508-513
ISSN: 0031-7144
Indexing
Other information
Authenticus ID: P-00F-RBG
Abstract (EN): A solid lipid nanoparticle (SLN) formulation, based on the lipid Imwitor® 900, was developed for the incorporation of the poorly water soluble drug RMEZ98. Physicochemical investigations were undertaken to examine the structure and physical stability of the selected lipid as colloidal dispersion in comparison to the bulk material. Using differential scanning calorimetry (DSC) and proton nuclear magnetic resonance (1H NMR) it could be assessed the influence of the incorporated drug on the structure of the lipid matrix. Investigation of mixtures of Imwitor® 900 and RMEZ98 showed an increasing effect on the melting/recrystallization behaviour with increasing drug content (5-30%). DSC and 1H NMR results revealed the formation of a crystalline matrix of SLN when prepared by high pressure homogenization excluding, therefore, the phenomenon of supercooled melt. After preparation of RMEZ98-loaded SLN, the drug remained inside the lipid matrix; however, it exhibited only a small effect on the recrystallization behaviour of Imwitor® 900 at the lowest payload required for a therapeutic effect (4% m/m with regard to the lipid matrix). Furthermore, the incorporation of RMEZ98 revealed no distinct influence on the particle size distribution. Imwitor® 900 proved to be a suitable lipid for the drug RMEZ98, i.e. possessing a sufficient loading capacity and simultaneously physical stability.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Of the same journal

Lipid nanoemulsions for anti-cancer drug therapy (2011)
Another Publication in an International Scientific Journal
Souto, EB; Nayak, AP; Murthy, RSR
Validation of an UV spectrophotometric assay for the quantification of polymyxin B in solid lipid nanoparticles (2015)
Article in International Scientific Journal
Severino, P; Silveira, EF; Vazzana, M; Chaud, MV; Santana, MHA; Souto, EB
The use of SLN (R) and NLC (R) as topical particulate carriers for imidazole antifungal agents (2006)
Article in International Scientific Journal
Souto, EB; Muller, RH
The use of SLN® and NLC® as topical participate carriers for imidazole antifungal agents (2006)
Article in International Scientific Journal
Souto, EB; Muller, RH
Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity (2006)
Article in International Scientific Journal
Weyhers, H; Ehlers, S; Hahn, H; Sout, EB; Muller, RH

See all (12)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-18 at 10:18:39 | Privacy Policy | Personal Data Protection Policy | Whistleblowing